Tuesday, August 5, 2014

PCP Addiction - End Your Addiction To Phencyclidine This Year


Phencyclidine or Angel dust is a very popular dissociative drug that was originally introduced back in the 1950s. It was taken off of the market as an
anesthetic for pharmaceutical uses once it was found that, in 1965, it had hallucinogenic side effects. It is able to work because it is a NMDA receptor antagonist, which means it blocks a glutamate receptor which affects memory function and also synaptic plasticity. By affecting these receptors, typical perceptions are distorted similar to what happens with ketamine. Here are some tips on how to avoid PCP addiction, and where you can get treatment for this drug.

What Does Angel Dust Do?

PCP goes by a number of different names, popular ones which include lack or Angel dust. People take it by swallowing it, or smoking it, and the effects can last well over an hour. If you have ever taken nitrous oxide or ketamine, the same effects will happen. PCP is dangerous in comparison to these other drugs as it has the ability to increase the amount of dopamine in your system which can also enhance the experience. Although it is only a schedule 2 substance in the United States, unlike cannabis which is a schedule 1, it is able to produce a trance like state which can also cause physical problems such as numbness, poor muscular coordination, profuse sweating, flushing and shallow breathing. In large doses, it has been shown to cause seizures, and even death, but death is typically the result of the hallucinations and people choosing to take their lives.

Getting Off Of PCP

PCP is something that you can free yourself from. You simply have to find a treatment center that can provide you with the hope that you need. If you are able to check into a treatment center, they will more than likely be able to help you resolve your problem in a very short period of time, helping to prevent your addiction from remaining, and potentially being physically hurt as a result of using Angel dust on a regular basis.

No comments:

Post a Comment